Tokyo, Japan

Katsuhiko Nagaoka

This inventor holds 1 USPTO granted patent. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuhiko Nagaoka. Retrieved from https://idiyas.com/inventor/katsuhiko-nagaoka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsuhiko Nagaoka

Introduction

Katsuhiko Nagaoka is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic substances. His work has had a notable impact on medical science, showcasing his dedication to innovation.

Latest Patents

Katsuhiko Nagaoka holds a patent for an antibiotic substance known as SS42227. This substance is represented by a specific formula, where X can be either >CH₂ or >C=CHOH. The substance exhibits antimicrobial and antitumor activities, making it a valuable asset in the medical field.

Career Highlights

Nagaoka is associated with Ss Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His expertise and innovative approach have led to the development of new medicinal compounds that address critical health issues.

Collaborations

Throughout his career, Katsuhiko Nagaoka has collaborated with notable colleagues, including Masaru Matsumoto and Koichi Yokoi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research.

Conclusion

Katsuhiko Nagaoka's contributions to the field of pharmaceuticals, particularly through his patent for the antibiotic substance SS42227, highlight his role as an influential inventor. His work continues to inspire advancements in medical science and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…